0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HIV Supplemental Assays and Control Kit Market Research Report 2026
Published Date: 2026-03-02
|
Report Code: QYRE-Auto-24T17924
Home | Market Reports | Health| Reproductive Health
Global HIV Supplemental Assays and Control Kit Market Research Report 2024
BUY CHAPTERS

Global HIV Supplemental Assays and Control Kit Market Research Report 2026

Code: QYRE-Auto-24T17924
Report
2026-03-02
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

HIV Supplemental Assays and Control Kit Market

The global HIV Supplemental Assays and Control Kit market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on HIV Supplemental Assays and Control Kit competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
HIV Supplemental Assays and Control Kits are crucial components in the laboratory diagnosis and confirmation of HIV (Human Immunodeficiency Virus) infection. These tools are used to validate initial screening results, ensuring accurate and reliable detection of HIV.
The North American market for HIV Supplemental Assays and Control Kit is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for HIV Supplemental Assays and Control Kit is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of HIV Supplemental Assays and Control Kit include Bio-Rad Laboratories, INSTI, Hologic, Sedia Biosciences Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global HIV Supplemental Assays and Control Kit market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding HIV Supplemental Assays and Control Kit. The HIV Supplemental Assays and Control Kit market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global HIV Supplemental Assays and Control Kit market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist HIV Supplemental Assays and Control Kit manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of HIV Supplemental Assays and Control Kit Market Report

Report Metric Details
Report Name HIV Supplemental Assays and Control Kit Market
Segment by Type
  • HIV-1 Test
  • HIV-2 Test
by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bio-Rad Laboratories, INSTI, Hologic, Sedia Biosciences Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for HIV Supplemental Assays and Control Kit manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines HIV Supplemental Assays and Control Kit sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the HIV Supplemental Assays and Control Kit Market report?

Ans: The main players in the HIV Supplemental Assays and Control Kit Market are Bio-Rad Laboratories, INSTI, Hologic, Sedia Biosciences Corporation

What are the Application segmentation covered in the HIV Supplemental Assays and Control Kit Market report?

Ans: The Applications covered in the HIV Supplemental Assays and Control Kit Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the HIV Supplemental Assays and Control Kit Market report?

Ans: The Types covered in the HIV Supplemental Assays and Control Kit Market report are HIV-1 Test, HIV-2 Test

1 HIV Supplemental Assays and Control Kit Market Overview
1.1 Product Definition
1.2 HIV Supplemental Assays and Control Kit by Type
1.2.1 Global HIV Supplemental Assays and Control Kit Market Value by Type: 2025 vs 2032
1.2.2 HIV-1 Test
1.2.3 HIV-2 Test
1.3 HIV Supplemental Assays and Control Kit by Application
1.3.1 Global HIV Supplemental Assays and Control Kit Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global HIV Supplemental Assays and Control Kit Market Size Estimates and Forecasts
1.4.1 Global HIV Supplemental Assays and Control Kit Revenue 2021–2032
1.4.2 Global HIV Supplemental Assays and Control Kit Sales 2021–2032
1.4.3 Global HIV Supplemental Assays and Control Kit Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 HIV Supplemental Assays and Control Kit Market Competition by Manufacturers
2.1 Global HIV Supplemental Assays and Control Kit Sales Market Share by Manufacturers (2021–2026)
2.2 Global HIV Supplemental Assays and Control Kit Revenue Market Share by Manufacturers (2021–2026)
2.3 Global HIV Supplemental Assays and Control Kit Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of HIV Supplemental Assays and Control Kit, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of HIV Supplemental Assays and Control Kit, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of HIV Supplemental Assays and Control Kit, Product Types and Applications
2.7 Global Key Manufacturers of HIV Supplemental Assays and Control Kit, Date of Entry into the Industry
2.8 Global HIV Supplemental Assays and Control Kit Market Competitive Situation and Trends
2.8.1 Global HIV Supplemental Assays and Control Kit Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global HIV Supplemental Assays and Control Kit Players Market Share by Revenue
2.8.3 Global HIV Supplemental Assays and Control Kit Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HIV Supplemental Assays and Control Kit Market Scenario by Region
3.1 Global HIV Supplemental Assays and Control Kit Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global HIV Supplemental Assays and Control Kit Sales by Region: 2021–2032
3.2.1 Global HIV Supplemental Assays and Control Kit Sales by Region: 2021–2026
3.2.2 Global HIV Supplemental Assays and Control Kit Sales by Region: 2027–2032
3.3 Global HIV Supplemental Assays and Control Kit Revenue by Region: 2021–2032
3.3.1 Global HIV Supplemental Assays and Control Kit Revenue by Region: 2021–2026
3.3.2 Global HIV Supplemental Assays and Control Kit Revenue by Region: 2027–2032
3.4 North America HIV Supplemental Assays and Control Kit Market Facts & Figures by Country
3.4.1 North America HIV Supplemental Assays and Control Kit Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America HIV Supplemental Assays and Control Kit Sales by Country (2021–2032)
3.4.3 North America HIV Supplemental Assays and Control Kit Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe HIV Supplemental Assays and Control Kit Market Facts & Figures by Country
3.5.1 Europe HIV Supplemental Assays and Control Kit Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe HIV Supplemental Assays and Control Kit Sales by Country (2021–2032)
3.5.3 Europe HIV Supplemental Assays and Control Kit Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HIV Supplemental Assays and Control Kit Market Facts & Figures by Region
3.6.1 Asia Pacific HIV Supplemental Assays and Control Kit Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific HIV Supplemental Assays and Control Kit Sales by Region (2021–2032)
3.6.3 Asia Pacific HIV Supplemental Assays and Control Kit Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HIV Supplemental Assays and Control Kit Market Facts & Figures by Country
3.7.1 Latin America HIV Supplemental Assays and Control Kit Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America HIV Supplemental Assays and Control Kit Sales by Country (2021–2032)
3.7.3 Latin America HIV Supplemental Assays and Control Kit Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HIV Supplemental Assays and Control Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa HIV Supplemental Assays and Control Kit Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa HIV Supplemental Assays and Control Kit Sales by Country (2021–2032)
3.8.3 Middle East and Africa HIV Supplemental Assays and Control Kit Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HIV Supplemental Assays and Control Kit Sales by Type (2021–2032)
4.1.1 Global HIV Supplemental Assays and Control Kit Sales by Type (2021–2026)
4.1.2 Global HIV Supplemental Assays and Control Kit Sales by Type (2027–2032)
4.1.3 Global HIV Supplemental Assays and Control Kit Sales Market Share by Type (2021–2032)
4.2 Global HIV Supplemental Assays and Control Kit Revenue by Type (2021–2032)
4.2.1 Global HIV Supplemental Assays and Control Kit Revenue by Type (2021–2026)
4.2.2 Global HIV Supplemental Assays and Control Kit Revenue by Type (2027–2032)
4.2.3 Global HIV Supplemental Assays and Control Kit Revenue Market Share by Type (2021–2032)
4.3 Global HIV Supplemental Assays and Control Kit Price by Type (2021–2032)
5 Segment by Application
5.1 Global HIV Supplemental Assays and Control Kit Sales by Application (2021–2032)
5.1.1 Global HIV Supplemental Assays and Control Kit Sales by Application (2021–2026)
5.1.2 Global HIV Supplemental Assays and Control Kit Sales by Application (2027–2032)
5.1.3 Global HIV Supplemental Assays and Control Kit Sales Market Share by Application (2021–2032)
5.2 Global HIV Supplemental Assays and Control Kit Revenue by Application (2021–2032)
5.2.1 Global HIV Supplemental Assays and Control Kit Revenue by Application (2021–2026)
5.2.2 Global HIV Supplemental Assays and Control Kit Revenue by Application (2027–2032)
5.2.3 Global HIV Supplemental Assays and Control Kit Revenue Market Share by Application (2021–2032)
5.3 Global HIV Supplemental Assays and Control Kit Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bio-Rad Laboratories
6.1.1 Bio-Rad Laboratories Company Information
6.1.2 Bio-Rad Laboratories Description and Business Overview
6.1.3 Bio-Rad Laboratories HIV Supplemental Assays and Control Kit Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bio-Rad Laboratories HIV Supplemental Assays and Control Kit Product Portfolio
6.1.5 Bio-Rad Laboratories Recent Developments/Updates
6.2 INSTI
6.2.1 INSTI Company Information
6.2.2 INSTI Description and Business Overview
6.2.3 INSTI HIV Supplemental Assays and Control Kit Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 INSTI HIV Supplemental Assays and Control Kit Product Portfolio
6.2.5 INSTI Recent Developments/Updates
6.3 Hologic
6.3.1 Hologic Company Information
6.3.2 Hologic Description and Business Overview
6.3.3 Hologic HIV Supplemental Assays and Control Kit Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Hologic HIV Supplemental Assays and Control Kit Product Portfolio
6.3.5 Hologic Recent Developments/Updates
6.4 Sedia Biosciences Corporation
6.4.1 Sedia Biosciences Corporation Company Information
6.4.2 Sedia Biosciences Corporation Description and Business Overview
6.4.3 Sedia Biosciences Corporation HIV Supplemental Assays and Control Kit Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sedia Biosciences Corporation HIV Supplemental Assays and Control Kit Product Portfolio
6.4.5 Sedia Biosciences Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HIV Supplemental Assays and Control Kit Industry Chain Analysis
7.2 HIV Supplemental Assays and Control Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HIV Supplemental Assays and Control Kit Production Mode & Process Analysis
7.4 HIV Supplemental Assays and Control Kit Sales and Marketing
7.4.1 HIV Supplemental Assays and Control Kit Sales Channels
7.4.2 HIV Supplemental Assays and Control Kit Distributors
7.5 HIV Supplemental Assays and Control Kit Customer Analysis
8 HIV Supplemental Assays and Control Kit Market Dynamics
8.1 HIV Supplemental Assays and Control Kit Industry Trends
8.2 HIV Supplemental Assays and Control Kit Market Drivers
8.3 HIV Supplemental Assays and Control Kit Market Challenges
8.4 HIV Supplemental Assays and Control Kit Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global HIV Supplemental Assays and Control Kit Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global HIV Supplemental Assays and Control Kit Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global HIV Supplemental Assays and Control Kit Market Competitive Situation by Manufacturers in 2025
 Table 4. Global HIV Supplemental Assays and Control Kit Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global HIV Supplemental Assays and Control Kit Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global HIV Supplemental Assays and Control Kit Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global HIV Supplemental Assays and Control Kit Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market HIV Supplemental Assays and Control Kit Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of HIV Supplemental Assays and Control Kit, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of HIV Supplemental Assays and Control Kit, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of HIV Supplemental Assays and Control Kit, Product Types and Applications
 Table 12. Global Key Manufacturers of HIV Supplemental Assays and Control Kit, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global HIV Supplemental Assays and Control Kit Companies by Tier (Tier 1, Tier 2, Tier 3), based on HIV Supplemental Assays and Control Kit Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global HIV Supplemental Assays and Control Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global HIV Supplemental Assays and Control Kit Sales by Region (K Units), 2021–2026
 Table 18. Global HIV Supplemental Assays and Control Kit Sales Market Share by Region (2021–2026)
 Table 19. Global HIV Supplemental Assays and Control Kit Sales by Region (K Units), 2027–2032
 Table 20. Global HIV Supplemental Assays and Control Kit Sales Market Share by Region (2027–2032)
 Table 21. Global HIV Supplemental Assays and Control Kit Revenue by Region (US$ Million), 2021–2026
 Table 22. Global HIV Supplemental Assays and Control Kit Revenue Market Share by Region (2021–2026)
 Table 23. Global HIV Supplemental Assays and Control Kit Revenue by Region (US$ Million), 2027–2032
 Table 24. Global HIV Supplemental Assays and Control Kit Revenue Market Share by Region (2027–2032)
 Table 25. North America HIV Supplemental Assays and Control Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America HIV Supplemental Assays and Control Kit Sales by Country (K Units), 2021–2026
 Table 27. North America HIV Supplemental Assays and Control Kit Sales by Country (K Units), 2027–2032
 Table 28. North America HIV Supplemental Assays and Control Kit Revenue by Country (US$ Million), 2021–2026
 Table 29. North America HIV Supplemental Assays and Control Kit Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe HIV Supplemental Assays and Control Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe HIV Supplemental Assays and Control Kit Sales by Country (K Units), 2021–2026
 Table 32. Europe HIV Supplemental Assays and Control Kit Sales by Country (K Units), 2027–2032
 Table 33. Europe HIV Supplemental Assays and Control Kit Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe HIV Supplemental Assays and Control Kit Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific HIV Supplemental Assays and Control Kit Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific HIV Supplemental Assays and Control Kit Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific HIV Supplemental Assays and Control Kit Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific HIV Supplemental Assays and Control Kit Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific HIV Supplemental Assays and Control Kit Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America HIV Supplemental Assays and Control Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America HIV Supplemental Assays and Control Kit Sales by Country (K Units), 2021–2026
 Table 42. Latin America HIV Supplemental Assays and Control Kit Sales by Country (K Units), 2027–2032
 Table 43. Latin America HIV Supplemental Assays and Control Kit Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America HIV Supplemental Assays and Control Kit Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa HIV Supplemental Assays and Control Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa HIV Supplemental Assays and Control Kit Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa HIV Supplemental Assays and Control Kit Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa HIV Supplemental Assays and Control Kit Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa HIV Supplemental Assays and Control Kit Revenue by Country (US$ Million), 2027–2032
 Table 50. Global HIV Supplemental Assays and Control Kit Sales (K Units) by Type (2021–2026)
 Table 51. Global HIV Supplemental Assays and Control Kit Sales (K Units) by Type (2027–2032)
 Table 52. Global HIV Supplemental Assays and Control Kit Sales Market Share by Type (2021–2026)
 Table 53. Global HIV Supplemental Assays and Control Kit Sales Market Share by Type (2027–2032)
 Table 54. Global HIV Supplemental Assays and Control Kit Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global HIV Supplemental Assays and Control Kit Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global HIV Supplemental Assays and Control Kit Revenue Market Share by Type (2021–2026)
 Table 57. Global HIV Supplemental Assays and Control Kit Revenue Market Share by Type (2027–2032)
 Table 58. Global HIV Supplemental Assays and Control Kit Price (US$/Unit) by Type (2021–2026)
 Table 59. Global HIV Supplemental Assays and Control Kit Price (US$/Unit) by Type (2027–2032)
 Table 60. Global HIV Supplemental Assays and Control Kit Sales (K Units) by Application (2021–2026)
 Table 61. Global HIV Supplemental Assays and Control Kit Sales (K Units) by Application (2027–2032)
 Table 62. Global HIV Supplemental Assays and Control Kit Sales Market Share by Application (2021–2026)
 Table 63. Global HIV Supplemental Assays and Control Kit Sales Market Share by Application (2027–2032)
 Table 64. Global HIV Supplemental Assays and Control Kit Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global HIV Supplemental Assays and Control Kit Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global HIV Supplemental Assays and Control Kit Revenue Market Share by Application (2021–2026)
 Table 67. Global HIV Supplemental Assays and Control Kit Revenue Market Share by Application (2027–2032)
 Table 68. Global HIV Supplemental Assays and Control Kit Price (US$/Unit) by Application (2021–2026)
 Table 69. Global HIV Supplemental Assays and Control Kit Price (US$/Unit) by Application (2027–2032)
 Table 70. Bio-Rad Laboratories Company Information
 Table 71. Bio-Rad Laboratories Description and Business Overview
 Table 72. Bio-Rad Laboratories HIV Supplemental Assays and Control Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Bio-Rad Laboratories HIV Supplemental Assays and Control Kit Product
 Table 74. Bio-Rad Laboratories Recent Developments/Updates
 Table 75. INSTI Company Information
 Table 76. INSTI Description and Business Overview
 Table 77. INSTI HIV Supplemental Assays and Control Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. INSTI HIV Supplemental Assays and Control Kit Product
 Table 79. INSTI Recent Developments/Updates
 Table 80. Hologic Company Information
 Table 81. Hologic Description and Business Overview
 Table 82. Hologic HIV Supplemental Assays and Control Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Hologic HIV Supplemental Assays and Control Kit Product
 Table 84. Hologic Recent Developments/Updates
 Table 85. Sedia Biosciences Corporation Company Information
 Table 86. Sedia Biosciences Corporation Description and Business Overview
 Table 87. Sedia Biosciences Corporation HIV Supplemental Assays and Control Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Sedia Biosciences Corporation HIV Supplemental Assays and Control Kit Product
 Table 89. Sedia Biosciences Corporation Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. HIV Supplemental Assays and Control Kit Distributors List
 Table 93. HIV Supplemental Assays and Control Kit Customers List
 Table 94. HIV Supplemental Assays and Control Kit Market Trends
 Table 95. HIV Supplemental Assays and Control Kit Market Drivers
 Table 96. HIV Supplemental Assays and Control Kit Market Challenges
 Table 97. HIV Supplemental Assays and Control Kit Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of HIV Supplemental Assays and Control Kit
 Figure 2. Global HIV Supplemental Assays and Control Kit Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global HIV Supplemental Assays and Control Kit Market Share by Type: 2025 & 2032
 Figure 4. HIV-1 Test Product Picture
 Figure 5. HIV-2 Test Product Picture
 Figure 6. Global HIV Supplemental Assays and Control Kit Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global HIV Supplemental Assays and Control Kit Market Share by Application: 2025 & 2032
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global HIV Supplemental Assays and Control Kit Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global HIV Supplemental Assays and Control Kit Market Size (US$ Million), 2021–2032
 Figure 13. Global HIV Supplemental Assays and Control Kit Sales (K Units), 2021–2032
 Figure 14. Global HIV Supplemental Assays and Control Kit Average Price (US$/Unit), 2021–2032
 Figure 15. HIV Supplemental Assays and Control Kit Report Years Considered
 Figure 16. HIV Supplemental Assays and Control Kit Sales Share by Manufacturers in 2025
 Figure 17. Global HIV Supplemental Assays and Control Kit Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global HIV Supplemental Assays and Control Kit Players: Market Share by Revenue in HIV Supplemental Assays and Control Kit in 2025
 Figure 19. HIV Supplemental Assays and Control Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global HIV Supplemental Assays and Control Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America HIV Supplemental Assays and Control Kit Sales Market Share by Country (2021–2032)
 Figure 22. North America HIV Supplemental Assays and Control Kit Revenue Market Share by Country (2021–2032)
 Figure 23. United States HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe HIV Supplemental Assays and Control Kit Sales Market Share by Country (2021–2032)
 Figure 26. Europe HIV Supplemental Assays and Control Kit Revenue Market Share by Country (2021–2032)
 Figure 27. Germany HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific HIV Supplemental Assays and Control Kit Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific HIV Supplemental Assays and Control Kit Revenue Market Share by Region (2021–2032)
 Figure 34. China HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America HIV Supplemental Assays and Control Kit Sales Market Share by Country (2021–2032)
 Figure 42. Latin America HIV Supplemental Assays and Control Kit Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa HIV Supplemental Assays and Control Kit Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa HIV Supplemental Assays and Control Kit Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE HIV Supplemental Assays and Control Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of HIV Supplemental Assays and Control Kit by Type (2021–2032)
 Figure 53. Global Revenue Market Share of HIV Supplemental Assays and Control Kit by Type (2021–2032)
 Figure 54. Global HIV Supplemental Assays and Control Kit Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of HIV Supplemental Assays and Control Kit by Application (2021–2032)
 Figure 56. Global Revenue Market Share of HIV Supplemental Assays and Control Kit by Application (2021–2032)
 Figure 57. Global HIV Supplemental Assays and Control Kit Price (US$/Unit) by Application (2021–2032)
 Figure 58. HIV Supplemental Assays and Control Kit Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS